canatpeptideの年表
Novel Drug Approvals for 2023
In 2023, the U.S. Food and Drug Administration’s (FDA) Center for Drug Evaluation and Research (CDER) hit a significant milestone, approving 55 new drugs, an increase of nearly 50% from last year and second only to the all-time high of 2018 .
- できごと(0)
- by canatpeptide
- at 2024/01/19 10:30
«前へ
1
次へ»
